GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AbbVie Inc (LTS:0QCV) » Definitions » Accumulated other comprehensive income (loss)

AbbVie (LTS:0QCV) Accumulated other comprehensive income (loss) : $-2,334 Mil (As of Sep. 2024)


View and export this data going back to 2013. Start your Free Trial

What is AbbVie Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. AbbVie's Accumulated other comprehensive income (loss) for the quarter that ended in Sep. 2024 was $-2,334 Mil.

AbbVie's quarterly Accumulated other comprehensive income (loss) declined from Mar. 2024 ($-2,454 Mil) to Jun. 2024 ($-2,513 Mil) but then increased from Jun. 2024 ($-2,513 Mil) to Sep. 2024 ($-2,334 Mil).

AbbVie's annual Accumulated other comprehensive income (loss) increased from Dec. 2021 ($-2,899 Mil) to Dec. 2022 ($-2,199 Mil) but then declined from Dec. 2022 ($-2,199 Mil) to Dec. 2023 ($-2,305 Mil).

AbbVie Accumulated other comprehensive income (loss) Historical Data

The historical data trend for AbbVie's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AbbVie Accumulated other comprehensive income (loss) Chart

AbbVie Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accumulated other comprehensive income (loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3,596.00 -3,117.00 -2,899.00 -2,199.00 -2,305.00

AbbVie Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2,353.00 -2,305.00 -2,454.00 -2,513.00 -2,334.00

AbbVie Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

AbbVie Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of AbbVie's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

AbbVie Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AbbVie Inc (LTS:0QCV) » Definitions » Accumulated other comprehensive income (loss)
Comparable Companies
MRK PFE JNJ AMGN BMY GILD BIIB OGN SCLX AMRN LLY XSWX:ROG LSE:AZN XSWX:NOVN XPAR:SAN LSE:GSK TSE:4568 TSE:4519 XTER:BAYN SHSE:600276
Traded in Other Exchanges
ABBV:USA ABBV:Mexico 1ABBV:Italy 4ABd:UK 4AB:Germany ABBV:Canada ABBV34:Brazil 4AB:Bulgaria ABBV:Austria ABBV:Argentina
Address
1 North Waukegan Road, North Chicago, IL, USA, 60064-6400
Website
http://www.abbvieinvestor.com
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).

AbbVie Headlines

No Headlines